Skip to Content

Join the 'Methocarbamol' group to help and get support from people like you.

Methocarbamol News

Forward-Thinking Tips for Back Pain

Posted 19 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 18, 2017 – Back pain is common but not inevitable, an orthopedist says. Roughly eight out of 10 people will suffer significant back pain at least once in their lifetime – but there are ways to reduce the risk, said Dr. Mark Knaub of Penn State Hershey Medical Center. Muscle, ligament or tendon strains (soft tissue injuries) are the most common causes of back pain. These injuries ...

Medication Errors Occur Every 8 Minutes in U.S. Children

Posted 20 Oct 2014 by Drugs.com

MONDAY, Oct. 20, 2014 – A child receives the wrong medication or the wrong dosage every eight minutes in the United States, according to a recent study. Nearly 700,000 children under 6 years old experienced an out-of-hospital medication error between 2002 and 2012. Out of those episodes, one out of four children was under a year old. As the age of children decreased, the likelihood of an error ...

FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient

Posted 21 Feb 2013 by Drugs.com

Reumofan Plus USA, LLC and Reumofan USA, LLC is recalling "Reumofan Plus" Tablets, Lot# 99515, exp. 09/16, because they contain undeclared active pharmaceutical ingredients: methocarbamol, dexamethasone, and diclofenac. The recall was initiated after it was discovered that the product was distributed in packaging that did not reveal the presence of the active pharmaceutical ingredients, making it ...

FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients

Posted 21 Dec 2012 by Drugs.com

ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.”  The product is being marketed to treat arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.  FDA laboratory analysis confirmed that “WOW” contains the same prescription drug ingredients ...

FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient

Posted 2 Jun 2012 by Drugs.com

ISSUE: FDA is warning consumers that Reumofan Plus, marketed as a natural dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful. An FDA laboratory analysis of Reumofan Plus found that it contains Diclofenac Sodium, a prescription non-steroidal anti-inflammatory drug (NSAID) that may cause ...

Ask a Question

Further Information

Related Condition Support Groups

Opiate Withdrawal, Muscle Spasm, Tetanus

Related Drug Support Groups

Robaxin, Robaxin-750, Carbacot, Skelex

Methocarbamol Patient Information at Drugs.com